ReviewWorld journal of surgical oncology2026
A new paradigm for esophageal disease management: the application and future prospects of Shared Decision Making (SDM).
Review in World journal of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Shared Decision Making (SDM), as a "patient-centered" medical decision-making model, has gradually demonstrated its application value in the diagnosis and treatment of esophageal diseases. This study is a structured narrative review (without quantitative synthesis or heterogeneity assessment). This structured narrative review systematically searched databases including PubMed, Cochrane Library, and China National Knowledge Infrastructure (CNKI) from 1990 to 2026 for clinical studies, meta-analyses, and guideline documents related to SDM in the field of esophageal diseases.It clarified the application scenarios and implementation pathways of SDM in major esophageal diseases such as esophageal cancer and gastroesophageal reflux disease. especially focusing on surgical decision-making in esophageal cancer.Meanwhile, based on the Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria, this study critically analyzed the advantages of SDM in enhancing patient decision-making satisfaction, optimizing the doctor-patient relationship, and formulating individualized treatment plans. It also objectively expounded on real-world challenges, including the lag in physicians' conceptual transformation, variations in patients' ability to participate, and limitations in medical resources. This study innovatively constructed a three-dimensional SDM implementation framework of "disease classification - evidence hierarchy - patient preference" and proposed differentiated application strategies tailored to the clinical characteristics of different esophageal diseases. The research findings provide evidence-based support for the standardized application of SDM in clinical practice for esophageal diseases and lay a foundation for clarifying future research directions in this field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.